Suzette Warren

490 total citations · 1 hit paper
7 papers, 300 citations indexed

About

Suzette Warren is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Nutrition and Dietetics. According to data from OpenAlex, Suzette Warren has authored 7 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Nutrition and Dietetics. Recurrent topics in Suzette Warren's work include Potassium and Related Disorders (6 papers), Electrolyte and hormonal disorders (4 papers) and Heart Failure Treatment and Management (3 papers). Suzette Warren is often cited by papers focused on Potassium and Related Disorders (6 papers), Electrolyte and hormonal disorders (4 papers) and Heart Failure Treatment and Management (3 papers). Suzette Warren collaborates with scholars based in United States, United Kingdom and France. Suzette Warren's co-authors include Bryan Williams, Martha Mayo, William B. White, Rajiv Agarwal, Alain Romero, Patrick Rossignol, Dahlia Garza, Jia Ma, David M. Spiegel and Pablo E. Pérgola and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Suzette Warren

6 papers receiving 294 citations

Hit Papers

Patiromer versus placebo to enable spironolactone use in ... 2019 2026 2021 2023 2019 50 100 150 200

Peers

Suzette Warren
Suzette Warren
Citations per year, relative to Suzette Warren Suzette Warren (= 1×) peers Silvia J. Leon

Countries citing papers authored by Suzette Warren

Since Specialization
Citations

This map shows the geographic impact of Suzette Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzette Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzette Warren more than expected).

Fields of papers citing papers by Suzette Warren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzette Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzette Warren. The network helps show where Suzette Warren may publish in the future.

Co-authorship network of co-authors of Suzette Warren

This figure shows the co-authorship network connecting the top 25 collaborators of Suzette Warren. A scholar is included among the top collaborators of Suzette Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzette Warren. Suzette Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rossignol, Patrick, Bryan Williams, Martha Mayo, et al.. (2020). Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( AMBER ): Results in the Pre-Specified Subgroup with Heart Failure. European Journal of Heart Failure. 22(8). 1462–1471. 25 indexed citations
2.
Agarwal, Rajiv, Patrick Rossignol, Alain Romero, et al.. (2019). Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. 394(10208). 1540–1550. 215 indexed citations breakdown →
3.
Williams, Bryan, Rajiv Agarwal, Patrick Rossignol, et al.. (2019). Patiromer vs. Placebo to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in Prespecified Subgroups. Journal of Cardiac Failure. 25(11). 939–939. 1 indexed citations
4.
Bushinsky, David A., David M. Spiegel, Jinwei Yuan, et al.. (2018). Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral Metabolism. Clinical Journal of the American Society of Nephrology. 14(1). 103–110. 13 indexed citations
5.
Agarwal, Rajiv, Patrick Rossignol, Dahlia Garza, et al.. (2018). Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study. American Journal of Nephrology. 48(3). 172–180. 17 indexed citations
6.
Pérgola, Pablo E., David M. Spiegel, Suzette Warren, Jinwei Yuan, & Matthew R. Weir. (2017). Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study. American Journal of Nephrology. 46(4). 323–332. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026